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Abstract
The combination of magnetic nanoparticles and a biocompatible material leads
to the manufacturing of a multifunctional and remotely controlled platform useful
for diverse biomedical issues. If a static magnetic field is applied, a magnetic scaf-
fold behaves like an attraction platform for magnetic carriers of growth factors,
thus being a potential tool to enhance magnetic drug delivery in regenerative
medicine. To translate in practice this potential application, a careful and critical
description of the physics and the influence parameter is required. This chapter
covers the mathematical modeling of the process and assesses the problem of
establishing the influence of the drug delivery system on tissue regeneration. On the
other hand, if a time-varying magnetic field is applied, the magnetic nanoparticles
would dissipate heat, which can be exploited to perform local hyperthermia treat-
ment on residual cancer cells in the bone tissue. To perform the treatment planning,
it is necessary to account for the modeling of the intrinsic nonlinear nature of the
heat dissipation dynamic in magnetic prosthetic implants. In this work, numeric
experiments to investigate the physiopathological features of the biological system,
linked to the properties of the nanocomposite magnetic material, to assess its
effectiveness as therapeutic agents are presented.
Keywords: biomaterials, bone tumors, bone repair, drug delivery, hyperthermia,
magnetic nanoparticles, RF heating, scaffolds
1. Introduction
Nanotechnologies aim to ease and to satisfy the needs of regenerative medicine1
by providing multifunctional, theranostic, and stimuli-responsive biomaterials
[1, 2]. In particular, stimuli-responsive biomaterials such as magneto-responsive
biomaterials are devices capable of reacting to an external magnetic field spatio-
temporally in a specific way [3]. This powerful class of biomaterials is a promising
candidate as active and therapeutic scaffolds for advanced drug delivery and tissue
regeneration applications [3, 4].
Multifunctional magnetic-responsive materials can be manufactured by modi-
fying or functionalizing traditional materials employed in tissue engineering or by
1
Regenerative medicine is a tissue regeneration technique based on the replacement or repair of diseased
tissue or organs to restore a lost or impaired function [1].
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incorporating magnetic nanoparticles (MNPs) in the biocompatible matrix [4, 5].
Table 1 reports examples of several magnetic biomaterials synthesized in the liter-
ature [6]. An approach to create a magnetic biomaterial is the impregnation of a
polymer or ceramic (e.g., ϵ-poly caprolactone or hydroxyapatite) with MNPs dis-
persed in a ferrofluid (FF) [5, 6]. Subject to the action of capillarity, the
nanoparticles fill the superficial defects and pores of the biomaterials. In this way
a nanocomposite is created, i.e., the final material is a two-phase system strength-
ened by the magnetic iron phase [7]. Moreover, a multifunctional and composite
material of such type can be obtained by the polymerization of a polymer in the
presence of magnetic nanoparticles of magnetite (Fe3O4) or maghemite (γ-Fe2O3).
This allows to produce a solid object using rapid prototyping and additive
manufacturing techniques, such as electrospinning or 3D bioplotting [7].
In alternative, a stable, repeatable, and controllable manufacturing technique of
magnetic-responsive biomaterial is the chemical doping of or substitution with F2þ
or F3þ ions in a ceramic material (e.g., hydroxyapatite, β-tricalcium phosphate, and
hardystonite). This process gives rise to an intrinsic magnetic and biocompatible
material, which can be used in the form of microparticles or directly as a bulk object
with tunable and ad hoc properties for therapeutic or regenerative medicine
applications [8, 9].
Given these methods, the magnetic biomaterial can be processed to develop a
tissue-guiding structure or a tissue scaffold, i.e., a device intended to be implanted
in an injured site for supporting and withstanding the cell adhesion, proliferation,
and differentiation, in order to restore tissue continuity and functioning [10].
Magnetic scaffolds (MagS) have been proposed for the following three main
applications, as presented in Figure 1 [1–9]:
Type of scaffold Synthesis technique Ms, emug1 Type of MNPs rmnp
HA/collagen Impregnation 0.35–15 Fe3O4 200
HA/collagen Impregnation 0.50 γ-Fe2O3, Fe3O4 10–50
HA/PLA Electrospinning 0.05 γ-Fe2O3 5
β-TCP Impregnation 0.6–1.2 Fe3O4 250
Chitosan/PVA membrane Electrospinning 0.7–3.2 Fe3O4 n.s.
Calcium silicate/chitosan Mixture 6–10 SrFe12O19 500
PMMA Mixture n.s. Fe3O4 10
Silicate Mixture n.s. γ-Fe2O3 n.s.
Fe-doped HA Chemical substitution 4 HA-Fe3O4 10–14
Fe-hardystonite Chemical doping 0.1–1.2 Fe3O4 20–60
Bredigite Milling 7–25 Ca7MgSi4O16-Fe3O4 120
HA Impregnation 12–20 Fe3O4 200
HA Impregnation 1–2.5 γ-Fe2O3 8
HA Impregnation n.s. γ-Fe2O3 5
Chitosan In situ precipitation 4 γ-Fe2O3, Fe3O4 n.s
ϵ-PCL 3D Bioplotting 0.2–0.3 Fe3O4 25–30
PLGA Electrospinning 2–10 Fe3O4 8.47
Table 1.
Magnetic scaffolds divided by composition, production, and MNPs embedded. Redrafted from [5].
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• To provide a controlled mechanical stimulation of tissues and boost the healing
response
• To develop a smart and reliable magnetic drug delivery system (MDD)
• To generate therapeutic heat and perform local hyperthermia (HT) against
cancer cells
The mechanical stimulation of injured tissues using magneto-responsive scaf-
folds found application in bone tissue engineering, where static magnetic field
(SMF) or low-frequency magnetic field is used to elicit osteoprogenitor cells [1–4].
The rationale of employing magnetic scaffolds as part of a MDD system is the
need to have an “attraction platform” to target and control the attraction of mag-
netic liposomes or MNPs bio-conjugated with growth factors (GFs) [6, 11]. Indeed,
recently several magnetic carriers of biomolecules capable of acting on cell function
were developed. However, using an external SMF their delivery to deep tissue and
to the site of damage is complicated, and the MNPs tend to distribute where the
magnetic force is maximum, i.e., at the body surface, where the field is applied [12].
Having a MagS implanted in the injured tissue allows to attract the MNPs and the
GFs while controlling their spatial distribution [13].
Finally, if the external magnetic stimulus is a radio-frequency (RF) magnetic
field, the population of MNPs embedded in the biomaterial dissipates a huge
amount of heat. The deposited power can be exploited as therapeutic heat, enabling
to use the magnetic scaffold as a thermo-seed able to perform HT treatment against
cancer cells [14].
To date, magnetic scaffolds have been synthesized and characterized in terms of
chemical and physical properties while proving experimentally their powerful and
promising potential in regenerative medicine and oncology [1–4]. However, to
translate the use of these nanostructured biomaterials in the clinical practice, sev-
eral limitations have to be overcome, and further investigations are required to
predict their behavior [4]. The potential use of magnetic scaffolds as tissue sub-
stitutes needs the combined work of material scientists, biomedical engineers, and
biologists. In particular, since in the literature there is a clear lack of mathematical
and numerical models, which relate the physical properties of these nanocomposite
Figure 1.
Magnetic scaffolds are obtained by the combination of biomaterials and MNPs. They are multifunctional and
theranostic nanocomposites. The potential biomedical applications of MagS are shown.
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biomaterials with the magnetic drug delivery or the hyperthermia, in this chapter,
two mathematical models for their use as hyperthermia agent and as a tool for
magnetic drug delivery are provided.
Section 2 briefly reviews the use of MagS as magneto-responsive biomaterials for
the stimulation of tissues, in particular bone tissues. In Section 3 the nonlinear
chemico-physical properties of magnetic scaffolds are presented, described, and
used to introduce a recent in silico model for the planning of bone tumor hyper-
thermia [14]. Finally, in Section 4 the use of MagS as tool for active magnetic drug
delivery is discussed. Furthermore, a mathematical model able of providing insights
into the parameters of influence of the phenomenon is presented and analyzed [13].
The complete description of magnetic scaffolds favors the assessment of their
effectiveness and their potential clinical impact.
2. Magnetic scaffolds for tissue repair and regeneration
Magnetic scaffolds have been tested both in vitro and in vivo, using animal
models, demonstrating that they can transduce an external magnetic signal in
mechanical stimulation to the cells attached to the biomaterial surface (Figure 1)
[1–4]. MagS have been investigated for bone, cartilage, cardiovascular and neuronal
regeneration, and repair [2]. The most studied tissue is bone. The injury of skeletal
tissue by traumas and diseases, such as osteoporosis, or by a tumor resection calls
for the need of a bone substitute or scaffold to guide cell adhesion, proliferation,
and differentiation [15]. Moreover, the bone tissue requires a continuous mechani-
cal stimulation. Therefore, the magneto-responsive biomaterials in Table 1 can
deliver a direct mechanical stimulation if exposed to SMF, to low-frequency mag-
netic field (strengths from to 18 μT to 0.6 T, frequencies varying from 10 to
76.6 Hz), or to pulsed electromagnetic fields [4]. The mechanism of action is not
fully understood yet. The presence of magnetic nanoparticles in the biomaterials
determines an increased superficial roughness and favors the interaction at the cell
membrane with the cell surface receptors. It has been demonstrated that the mes-
enchymal stem cells (MSCs) can differentiate into osteoblast thanks to the activa-
tion of the integrin signaling pathways, which upregulate the expression of the
osteogenic GF bone morphogenetic protein 2 (BMP-2) [4]. The use of magnetic
scaffolds permits the integration of the implant with the host tissue, accelerating the
defect healing and increasing the mineral density of newly formed bone.
3. The hyperthermia treatment of bone tumors
3.1 The heat dissipation of magnetic nanoparticles
To understand the magnetization dynamic and the power losses of magnetic
scaffolds, it is necessary to introduce the physical and mathematic descriptions of
the response to a RF magnetic field of the MNPs embedded in it. If a population of
magnetic nanoparticles in a solution is exposed to a harmonic RF magnetic field,
they start to dissipate power due to the hysteresis loss but also to the magnetic
dipole and to the Brownian relaxations [16]:
Pm ¼ πμ0 f Hj j2χ00 (1)
where μ0 is the vacuum permeability; f is the frequency of the applied field, in
Hz;H is the amplitude of the external magnetic field; and χ00 is the imaginary part of
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the complex magnetic susceptibility of the particles. For ferrofluids, the magnetic
susceptibility is known to be described by the Debye model [13, 16]:
χ fð Þ ¼ χ0  jχ00 ¼ χ0
1þ j2πf τ (2)
The term χ0 is the equilibrium susceptibility that is defined as [17]:
χ0 ¼ χi
3
ζ
coth ζð Þ  1
ζ
 
(3)
where ζ is the ratio between the magnetic energy of the set of magnetic dipoles
and the thermal energy. Mathematically speaking:
ζ Tð Þ ¼ μ0ϕM
2
sVmnp∣H∣
3kBT
(4)
where Ms is the saturation magnetization of the single MNPs, in Am1; Vmnp is
the particle volume in nm3; kB is the Boltzmann’s constant; and T is system tem-
perature. In Eq. (3), χ0 is the initial susceptibility, which is defined as [17]:
χi H,T
  ¼ μ0ϕMsVm∣H∣
3kBT
(5)
The term τ in the Debye model (Eq. 2) is the effective relaxation time, in s,
which can be evaluated as the parallel of the Néel and Brownian processes [17]:
1
τ
¼ 1
τN
þ 1
τB
(6)
The time required to the magnetic dipole moment to align with the direction of
the external magnetic field is called the Néel relaxation time, τN [16, 17]:
τN ¼
ffiffiffi
π
p
2
τ0
eΓ
Γ
(7)
The pre-exponential factor τ0 is a time, and its value can range from 0.1 ps to
1 ns, but this term is a function of system temperature, i.e., τ0 ¼ τ0 Tð Þ [13]. The
term Γ is the ratio of the anisotropy energy of the nanoparticle to the thermal
energy of the system, i.e.:
Γ ¼ KaVm
kBT
(8)
where Ka is the magnetic anisotropy energy per unit volume in Jm3 and Vm is
the MNP volume in nm3.
In a FF, the nanoparticles are allowed to rotate and move according to Brownian
motion in the viscous medium where they are dispersed. When subject to a time-
varying magnetic field, the particles rotate to orient with the direction of the
external energy source, thus contributing to the relaxation process. The Brownian
relaxation time can be evaluated as [16]:
τB η,Tð Þ ¼ 3ηVh
kBT
(9)
being η the viscosity of the medium, in Pas, and Vh the hydrodynamic radius of
the particle in solution.
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With Eqs. (1) to (9), it is possible to describe the frequency response and the
power dissipation of a population of MNPs dispersed in a solution. This set of
equations constitutes the theoretical basis for the understanding of magnetic scaf-
fold behavior. However, since MagS are solid nanocomposites, the behavior of their
magnetic phase is rather diverse than a FF. In the following, the experimental
findings related to material characterizations and a new mathematical framework to
account for their response are provided.
3.2 Hyperthermia response of magnetic scaffolds
Hyperthermia (HT) is a thermotherapy which aims at increasing the tempera-
ture of a target tissue between 41 and 46 C for about 60 min. For biological tissues,
especially neoplasms and cancers, these temperatures are sufficient to damage the
DNA of cells, altering its replication and also the repair pathways while determining
cytotoxicity and activating the response of the host immune system [18, 19]. The
rather chaotic vascular architecture of tumors is the reason of the thermo-sensibility
of these pathologic tissues. The aforementioned biological effects can lead to the
death of cancer cells, but, in the clinical practice, HT is exploited as a coadjuvant
therapy combined with chemotherapy or/and radiotherapy rather than as a
standalone therapy [19]. The hyperthermia can be induced using different types of
energies, such as ultrasounds or electromagnetic (EM) field [14]. Currently differ-
ent therapeutic modalities are available for HT induced by EM field. In particular, it
is thoroughly investigated the local and in situ treatments using nanoparticles or
magnetic scaffolds by exposing the target are with an external magnetic field.
Several magnetic scaffolds from Table 1 demonstrated to be capable of notice-
able temperature increases when exposed to magnetic field working at the frequen-
cies from 100 kHz to 1 MHz and with amplitude ranging from 8 to 25 kAm1 [5, 7].
Different biomaterials (e.g., hydroxyapatite, β-TCP, and PCL) loaded with magne-
tite or maghemite nanoparticle temperature increase, from room temperature, of 8–
45∘C, were measured [5]. In particular, on one hand, a scaffold made with the
intrinsic magnetic hydroxyapatite of Tampieri et al. [8] can increase the tempera-
ture of 40∘C in 60 s when exposed to a magnetic flux density with amplitude of 30
mT and frequency 293 kHz. On the other hand, in the same exposure conditions, a
PCL scaffold loaded with magnetite nanoparticles can raise the temperature from
20 to 32∘C in 600 s [7, 8, 13].
These composite nanomaterials are identified as optimal candidates for local
bone tumor hyperthermia [1–9, 13, 14]. However, their therapeutic potential must
be investigated in a critique way. The understanding and the modeling of the heat
dissipation of the MNPs embedded in the biomaterial are essential to allow an
effective treatment planning.
3.3 The susceptibility spectra of magnetic scaffolds
The physical explanation of the relevant and significant temperature increases
measured for MagS is not trivial. Moving from the theory explained in Section 3.1,
the resonant Debye model cannot be applied to a system in which highly concen-
trated MNPs are fixed and embedded in a solid matrix and lattice or constrained in a
highly viscous medium [13]. Indeed, the long-range interactions between the mag-
netic nanoparticles become relevant [20]. The following index ϒ, given in [20], can
be considered to estimate the level of dipole–dipole interactions in the nanosystem
under analysis:
6
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ϒ ¼
μ0μ
2
mnp
4πkBTd
3
mnp
(10)
where the cubic power of the particle diameter, d3mnp, is the lower limit of the
volume packaging and of the steric hindrance in the system [5]. For example, for
magnetite nanoparticles the particle diameter measured in dry condition with
transmission electron microscope (TEM) is lower than the hydrodynamic radius
assessed using dynamic light scattering (DLS), i.e., 10 nm against 25 nm. Therefore,
at the body temperature of 37∘C, given the same dipole moment μmnp, the level of
interaction of MNPs in solution is 2.5 times lower. It is demonstrated by the mor-
phological and structural characterization of MagS that the MNPs in the biomaterial
are often aggregated or very near, implying that small clusters of nanoparticles can
be identified [5]. Moreover, this last evidence supports the theory for which the
relaxation dynamic of clusters of MNPs is strongly modified due to the appearance
of a distribution of anisotropy energies [20]. In other words, the Neel relaxation
time in Eq. (7) will depend on the number and the dispersion of sizes of the
nanoparticles. Another limitation of the applicability of the Debye model to the
description of magnetic scaffolds is the influence of Brownian relaxation time on
the heat dissipation mechanism. It has been demonstrated that the frequency
response of the complex magnetic susceptibility χ fð Þ of MNPs modifies if the
particles are constrained in agarose gel or used as cross-linkers in hydrogels [21, 22].
This change in the susceptibility spectra is due to the fact that in a highly viscous
matrix or in a solid, the Brownian mechanism is hindered or canceled. From Eq. (9),
in mathematical terms:
lim
η!∞τB η,Tð Þ ! 0 (11)
Therefore, in MagS the only relaxation time is the Néel one.
The influence of long-range interactions between particles, the modified distri-
bution of anisotropy energy, and the different Néel relaxation dynamic are the
factors that contribute to enhance the power dissipation of magnetic scaffolds, and
all of them can help to explain the hyperthermia behavior of MagS, such as for the
magnetic hydroxyapatite and the Fe-doped PCL scaffolds [7]. Relying on the mag-
netic susceptibility spectra of MNPs in agarose gel measured by Hergt et al. [21], a
Cole-Cole model for magnetic scaffolds [13]:
χ ωð Þ ¼ χ0
1þ 2πf τð Þ1α (12)
Equation (12) can fit the susceptibility data, with a 1.5% relative error, as shown
in Figure 2, whereas the Debye model cannot (Eq. (2)). In Eq. (12) γ is the broad-
ening parameter, which is found to be equal to 0.75 [13]. The differences in the
frequency response are depicted in Figure 2.
With Eqs. (1)–(8), but using Eq. (12) instead of Eq. (2), it is possible to evaluate
and estimate the power losses of magnetic scaffolds. At this point it should be noted
that the magnetic susceptibility χ fð Þ is a function of the system temperature, which
influences the initial susceptibility and the Néel relaxation time (Eqs. (5) and (7)).
As the temperature increases, the therm τ0 increases, whereas the time τN
decreases. The outcome is a decrease in the imaginary part of the magnetic suscep-
tibility, χ00, which in turn lowers the power deposited by the magnetic scaffold.
Therefore, since the goal of hyperthermia treatment is to increase the temperature
7
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of cancer tissues, it follows that the magnetic properties of and hence the power
dissipated by MagS change during the treatment. The influence of temperature on
the different physical quantities is shown in Figure 3. Since P=P Tð Þ, planning a HT
treatment which employs MagS as thermo-seeds against tumors is a multiphysics
and highly nonlinear problem [14].
3.4 The hyperthermia treatment of bone tumors
Given the potential of magnetic scaffolds to be used as local heat source for
setting the hyperthermia treatment of cancers, the most studied biological and
clinical target of the nanosystems under investigation are bone cancers. Indeed, in
clinical practice, currently available techniques such as chemotherapy, radiother-
apy, and osteotomies presented a 15% probability of tumor recurrence, and there-
fore the hyperthermia treatment was proposed as adjuvant therapy [24].
Furthermore, since the surgical intervention causes a bone damage which calls for a
graft or bone substitutes, magnetic scaffolds as theranostic, multifunctional, and
magnetic-responsive biomaterials can be employed and can express their clinical
potential [14].
Bone tumors are neoplasms mostly affecting subjects with age between 10 and
25 years old, causing impairment and pain, thus ruining the quality of life [23].
Malignant bone cancers such as osteosarcoma (OST) and fibrosarcomas (FIB) are
known to affect long bone extremities [23]. OST and FIB are two different forms of
bone cancer. The OST is big, aggressive and highly vascularized, whereas FIB is a
poorly vascularized neoplasm. The survival rate for patients affected by OST and
Figure 3.
Temperature variation of the pre-exponential term τ0 and the Neel relaxation time τN. The influence on the
equilibrium and the complex magnetic susceptibility χ0 and χ fð Þ is represented. The curves are obtained for a
magnetic scaffold filled with the 0.2% of magnetite nanoparticles (rmnp=10 nm,Ms(0) = 2 emug1,Tb=150 K).
Figure 2.
Results of the fitting of the magnetic susceptibility spectra of MNPs embedded in agarose: a) real part (in-phase)
and b) imaginary (out-of-phase) components are presented [21]. The Debye and Cole-Cole models are used
and compared Taken from [13].
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FIB may vary from 28–40% [14, 23, 24]. To overcome these clinical issues, oncolo-
gist investigated the use of immunotherapy or smart nanocarriers of drugs, but local
hyperthermia stands out as a very promising therapy [14]. The rationale is to
implant a MagS after the bone tumor resection or reduction and then perform a
local and in situ hyperthermia treatment by applying an external RF magnetic field.
The residual cancer cells would be killed or increase their sensibility to drugs or
radiations. Finally, the scaffolds would serve as supporting architecture for healthy
cells, favoring tissue repair [14].
3.4.1 The in silico scenario
With the knowledge of the mechanism of power dissipation of MNPs embedded
in a scaffold, recently a numerical scenario, with layered geometry, was proposed
to investigate using finite element methods (FEM) the effectiveness of magnetic
scaffolds in treating the residual bone cells of OST and FIB tumors [14].
As shown in Figure 4, imagining a surgical intervention of a bone cancer in
distal femur, a spherical magnetic scaffold, with radius rs = 5 mm, is implanted to
fulfill the bone cavity [14]. A small gap or fracture (rf = 0.1 mm) separates the
scaffold from an annular region where the residual cancer cells of OST or FIB are
supposed to be found. The fracture gap is a heterogeneous region where blood and
bone are present, and it is where the new bone forms. It was demonstrated that its
presence and biological status, i.e., if it is inflamed or ischemic, can influence the
HT outcome [14]. The tumor area has a radius rt which can vary from 0.1 to
0.5 mm. The goal of the HT treatment is to raise the temperature above 42∘C for
30 min [14, 17]. Finally, a healthy bone tissue region with radius rb=5 mm is
included. The healthy bone should not be damaged by the treatment [5, 14]. It
should be pointed out that muscle, fat, or skin tissues are not included in this
analysis [25].
3.4.2 The electromagnetic problem
With respect to the geometry in Figure 4, the HT treatment using MagS is
carried out applying an external RF magnetic field with strength H0, working
frequency f (293 kHz or 409 kHz [14]), and a time envelope able to keep the target
temperature above the therapeutic threshold. The magnetic field is supposed to be
Figure 4.
Simplified layered geometry for modeling the hyperthermia treatment of bone tumors using magnetic scaffolds.
The MagS with radius rs = 5 mm is surrounded by a surgical fracture gap (rf = 0.1 mm), the area where residual
cancer cells are present (rt = 0.1 mm–0.5 mm), and the healthy bone tissue (rb = 5 mm). Taken from [14].
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homogeneous in space [14]. At the initial time, the system is supposed to be in
thermal equilibrium with a constant temperature distribution (T0=37∘C). Maxwell’s
equation in the frequency domain should be solved to calculate the power dissipated
in the system [5]:
∇H ¼ jω ϵ0Eþ J
 
∇ E ¼ jωμ0H
(13)
where ω is the angular frequency 2πf, ϵ0 is the vacuum permittivity in Fm1, E is
the electric field vector in Vm1, and, finally, J conduction current vector in the
system, in Am2. The total electromagnetic power dissipated is the sum of the power
density dissipated by the scaffold and the tissues, i.e., PEM = Pm + Pe. The power
deposited by the MagS, Pm, requires Eq. (13) to be solved considering the set of
Eqs. (1)–(8) but using Eq. (12) instead of (2). The power dissipated by the induced
currents in tissues (Pe) cannot be neglected, even though several mathematical
models related to magnetic hyperthermia did not include it [26]. However, the
dielectric losses in the system can have a significant contribution to the final
temperature increase while causing the unwanted indirect heating of the nontarget
tissues [5, 25].
The EM problem is solved employing the RF module of the commercial FEM
software COMSOL Multiphysics (COMSOL Inc., Burlington, MA). The MagS
studied are the intrinsic magnetic hydroxyapatite and the PCL loaded with magne-
tite [7], as in [14]. The dielectric properties of scaffold and tissues at T0 are reported
in Table 2.
3.4.3 The heat transfer problem
The power deposited by the MagS and conducted to the tissues in the system
of Figure 4 modifies the temperature (T ¼ T r, z, tð Þ), whose spatiotemporal
evolution can be evaluated using the Pennes’ bioheat equation [14]:
ρCp
∂T
∂t
¼ ∇  k∇Tð Þ þ ρbCp, bωb T  Tað Þ þ Qmet þ PEM (14)
where ρ is the density in gm3, Cp is the specific heat capacity in Jkg1K1, and
k is the thermal conductivity in Wm2K1. The terms ρb and Cb are the density and
heat capacity of blood, whereas the quantity ωb is the tissue perfusion, in s
1, i.e.,
the capillary contribution which acts to equilibrate the tissues with the blood tem-
perature Tb=37
∘C. QM is the metabolic heat rate generated by the tissues, in Wm3.
Material or tissue Re[ϵ] σ, Sm1
Magnetic hydroxyapatite 12.5 2.1103
ϵ-PCL 2.20 104
Fracture gap–inflamed 3580 0.545
Fracture gap–ischemic 1321 0.196
Bone tumors: OST and FIB 8000 0.280
Bone 192 0.0214
Table 2.
Electromagnetic properties of scaffolds and tissues [14].
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Eq. (14) was implemented in COMSOL using the Bio-Heat transfer module. The
initial temperature T0 was set in all domains. The bone edges are assumed to be
open boundaries. The temperature field is continuous at each tissue interface. The
thermal properties of materials and tissues employed are reported in Table 3.
The solution of Eq. (14) is a new temperature field. As previously discussed, the
different system temperature determines a change in the magnetic and heat dissi-
pation properties of the scaffolds. Also the dielectric and thermal properties of
tissues vary with temperature [14]. To account for the influence of these variations
on the outcome of HT treatment, the solution of Eq. (14) should be used to evaluate
the EM power solving Eq. (13) for the next time step; then the next temperature
distribution can be calculated considering the changed physical properties. This
solution scheme is justified by the rather different dynamic of the EM and thermal
fields [14].
In the temperature range 37∘C–47∘C of the HT treatment, the following linear
relationship between the property p (ϵ, σ, Cp, k) of each tissue and the system
temperature [5, 14, 25]:
Δp Tð Þ
p T0ð Þ ¼ 1þ cΔT (15)
The dielectric properties are assumed to increase linearly with c = 3% C1 [14].
The thermal properties, Cp and k, have been assumed to vary with c = 0.5%∘C1 and
0.33%∘C1, respectively [14]. An exception was made for the heat capacity of blood,
which presents a negative coefficient of 1%∘C1 [14].
In this condition the strength, frequency, and envelope of the external RF
magnetic field required to treat both osteosarcoma and fibrosarcoma cells were
investigated.
3.5 Results
The temperature pattern resulting from the exposure to the homogeneous RF
field is uniform and radial, as shown in Figure 5a. This is a consequence of the
homogeneous distribution of the MNPs in the biomaterials [7, 14]. After 60 min of
treatment, it can be noticed that the temperature in the healthy bone can reach
47∘C, which is a potentially harming value. To assess the performance of the two
types of MagS in treating OST and FIB, the average value of temperature in the
tumor region vs. time was considered. From Figure 5b it can be noticed that both
magnetic hydroxyapatite and Fe-doped PCL are able to treat the poorly
vascularized FIS for any given dimension of the residual area rt. This can be
explained considering that PEM≫∣ρbCp, bωb T  Tað Þ∣, for H0=10–17 mT. However,
Material or tissue k, Wm1K1 Cp, Jkg1K1 Q m, Wm3 ωb, s1
Magnetic hydroxyapatite 1.33 700 — —
ϵ-PCL 0.488 3359.2 — —
Fracture gap–inflamed 0.558 2450 5262.5 6:95  103
Fracture gap–ischemic 0.558 2450 5262.5 6:95  103
Bone tumors: OST and FIB 0.32 1313 57,240 2.42103 ÷ 0.595
Bone 0.32 1313 286.2 0.262103
Table 3.
Heat transfer properties of scaffolds and tissues [14].
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the temperature rise is noticeable, and the external field should be modulated (or
turned off) to keep the temperature closest to the target value of 42∘. In the case of
OST, give the high value of blood perfusion (see Table 3); not all MagS are able to
treat successfully the residual cancer cells. This is the most challenging tumor.
Indeed, the Fe-doped PCL scaffold fails to reach the lethal HT temperature for an
OST of 0.5 mm, even increasing the amplitude to 40 mT or the frequency to
409 kHz. The magnetic hydroxyapatite scaffold is more effective in treating the
residual osteosarcoma cells, as can be observed in Figure 5c. These results demon-
strate that the in HT treatment of residual bone tumor cells is feasible, and, with the
knowledge of the physico-chemical properties of the nanomaterial, the treatment
can be planned against different type of tumors.
4. Magnetic scaffolds and regenerative medicine
4.1 Magnetic drug delivery
Magnetic scaffolds were conceived as a multifunctional platform for tissue
engineering applications (see Figure 1) [1–5]. As presented in the Introduction,
they are a platform for magnetically targeted drug delivery of growth factors to
control and enhance tissue healing, such as in the case of bone tissue [1, 11]. The
bio-nanotechnology research developed magnetic carriers of biomolecules such as
VEGF or TGF-β [11, 27]; however, the problem of maximizing and controlling their
delivery to the site of injury is still addressed in the literature [1–4, 13]. This section
will cover the use of MagS, implanted in a damaged bone, as an in situ magnet, i.e.,
as attraction site for external MNPs carrying GFs. The influence on the cellular
response is assessed employing a multiphysics model [13]. The prediction of the
magnetic force required to attract the MNPs, the velocity in the extracellular matrix
(ECM) medium, and the final spatial distribution is fundamental to foresee a treat-
ment planning procedure, while evaluating the influence parameters in the drug
delivery and the cellular migration process.
4.2 Challenging the mathematical modeling of MDD
4.2.1 The magnetostatic problem
Considering the geometry of Figure 4, the analysis domain is limited to the
scaffold and the fracture gap, neglecting the bone tumor and assuming that only
healthy bone is present, in a way similar to [13]. The MagS and the gap have a radius
Figure 5.
(a) 2D temperature distribution after 60 min of treatment using a RF magnetic field of 30 mT and working at
293 kHz. A OST with rt=0.5 mm is considered. (b) Average temperature in the region with residual FIB cells.
(c) Average temperature in the region with residual OST cells. (MHA = magnetic hydroxyapatite).
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of 5 mm. An external uniform and static magnetic flux density field of strength B0
is supposed to be applied along the z-axis of the system. The magnetic composite
nanomaterial will magnetize in a nonlinear way according to the following
relationship [13]:
M ¼Msϕ coth ζð Þ  1
ζ
 
(16)
where all symbols have the previous definition. As presented in Table 1, the
magnetization response of the scaffolds varies from a minimum of 0.4 emug1 to a
maximum of 25 emug1. Considering this nonlinear material property, the problem
is the determination of the spatial distribution of the magnetic field, i.e., the
solution of the following magnetostatic problem employing the scalar magnetic
potential ψm [13]:
∇H ¼ 0
H ¼ ∇ψm
(17)
Due to the presence of the magnetic material, the magnetic field flux lines
concentrate in the prosthetic implant, implying that the norm of the gradient of
magnetic density field between the MagS and the diamagnetic tissues is relevant
[6]. In the literature, it is reported that if the magnetic density field gradients are
higher than 1.3 Tm1, then the magnetic force exerted on a population of sur-
rounding MNPs would be sufficient to overcome their weight force and set them in
motion toward the scaffold [13, 28]. This is a very simplified view of the problem.
Indeed, several relevant physical and biological factors took part to the transport
phenomena of MNP attraction to the MagS in the presence of a static magnetic field.
As defined by Grief and Richardson, the magnetic force vector Fm on an ensemble
of MNPs in saturation regime can be evaluated as follows [12]:
Fm ¼ Ms2Vm2
6kBT
∇ B
 2 (18)
where Ms2 and Vm2 are the saturation magnetization, in Am1, and the volume of
the spherical magnetic nanoparticles, in nm3, to be attracted, respectively. The
nanoparticles conjugated with growth factors or drugs are hence set in motion with
a velocity vm equal to [12, 13]:
vm ¼ Fm
6πηrm2
(19)
where rm2 is the radius of the magnetic carriers. The term η is the viscosity of the
medium in which the nanoparticles move, in Pas. This medium is often assumed
to be water (ηw=1103Pas); however, actually the MNPs that move from the
capillaries of bone tissues into the fracture gap are dragged in a solution of water,
proteins (e.g., collagen, fibrin, and plasmin), and other macromolecules. Therefore,
the extracellular matrix (ECM) can be assumed to be the medium in which the
MNPs move, implying that ηw=1103Pas [13].
After having solved Eq. (17) and calculated Eqs. (18) and (19), the spatiotemporal
distribution of the concentration of MNPs (Cmnp, molm3) functionalized with the
drug can be obtained computing the following diffusion-convection equation [13]:
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∂Cmnp
∂t
¼ ∇  Dmnp∇Cmnp
 	 vm∇Cmnp (20)
Dmnp is the diffusion coefficient of MNPs in the medium, assumed to be equal to
109ms2. The analytical mass balance is subject to the outflow condition at the
scaffold surface, while a constant initial concentration of MNPs (Cm,0) is assumed
at the host bone interface. In the fracture gap, it is assumed that
Cmnp r, z, t ¼ 0ð Þ ¼ 0 as initial condition.
The magnetic field distribution (Eq. (17)) is derived by solving numerically the
magnetostatic problem for the geometry depicted in Figure 4 using theMagnetic
Fields No Currents package from the AC/DC module of COMSOLMultiphysics. Then
vm is inserted in the Transport of Dilute Species interface to solve Eq. (20).
4.2.2 Including the cells and the biological elements
Now, we assume that the MDD system is constituted by an active GF with
concentration Cchemo present at the MNP surface. The presence of such specific
biomolecule is supposed to represent a direct chemotactic stimulus for the human
mesenchymal stem cells (MSCs) present in the surrounding host bone tissue [13].
Chemotaxis is the phenomenon of cellular migration directed toward a chemical
stimulus. This means that the osteoprogenitor cells can respond to the chemical
signaling stimulus carried by the MNPs. The magnitude of the chemotactic stimulus
can be assumed to be equal to [13]:
Kchemo ¼ Dc
Cchemo
(21)
Given Cmnp from Eq. (20), the spatial pattern of the MSCs exposed to the
biological signal carried by the MNPs is the solution of the mass balance for the cell
population Cc:
∂Cc
∂t
¼ ∇  Dc∇Cc  CcKchemo∇Cmnp
 	
(22)
Similar to Eq. (20), Eq. (22) is subject to Dirichlet and Neumann boundary
conditions, i.e., the diffusive flux of cell population should be null at the scaffold
surface, and the cell concentration at host bone is set to a constant value of Cc,0.
Moreover, the cell concentration in the fracture gap is assumed to be null at the
initial time.
With this set of equations, it is possible to model the role of magnetic scaffolds as
part of a MDD system studying the influence on the cellular migration and the
scaffold colonization, providing valuable insight into the use of MagS as a tool in
tissue engineering.
4.2.3 Results from the case study
The magnetic scaffolds exposed to the static magnetic flux density field B0
respond in a way similar to a uniformly magnetized sphere, as shown in Figure 6a.
As a matter of fact, the magnetic force and resulting velocity distribution are
similar, implying that the MNP concentration is maximum at the poles of the
scaffold, while it is minimum at the equator (Figure 6b). The generic GFs attached
to the MNPs are sensed by the cells, which migrate toward the chemical stimulus.
As shown by Figure 6, after only 24 h of migration, the MSCs invade the gap cavity
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and reach the biomaterial surface. This suggests that the cells can colonize the
scaffold and boost the regenerative process. From the model and the results
presented, the final cell density pattern can be predicted and controlled by tuning or
acting on the scaffolds magnetic properties or geometry [13].
5. Conclusions
This chapter presented an innovative family of nanocomposite magnetic bio-
materials and their biomedical applications. Mixing magnetic nanoparticles with
traditional biomaterials, e.g., polymer or ceramics, or chemically doping them
allows the manufacturing of a magnetic-responsive biomaterial with
multifunctional properties. The so-called magnetic scaffolds have been studied for
their ability to transduce an external magnetic signal into mechanical and biological
outcome, thus proving to be a powerful platform for cell and tissue stimulation
[1–4]. Exploiting the ability of the MNPs embedded in the biomaterial to dissipate
power when exposed to a radio-frequency magnetic field makes MagS a valid
candidate to perform local hyperthermia treatment on residual cancer cells. In this
chapter the physical properties and the magnetic susceptibility of these novel com-
posite nanosystems are investigated. Then an in silico model to study the feasibility
of employing MagS in the treatment of bone cancers, such as osteosarcomas and
fibrosarcomas, is presented [14]. The results indicate that further research on the
nanomaterial is required to develop an effective and tailored magnetic scaffold.
Finally, the potential of MagS to serve as an in vivo attraction site to enhance the
magnetic drug delivery of growth factors is faced. To predict the final concentration
pattern, a mathematical model which relates the nonlinear magnetic problem and
the mass transport issue is presented. Furthermore, the link between these two
aspects and the biological influence on cellular migration is challenged [13]. The
results indicate that MagS are able to attract MNPs and exert an indirect action on
MSCs in a way dependent on the geometrical and material properties.
Acknowledgements
The authors would like to sincerely thank Prof. G. Mazzarella for the helpful
discussions and suggestions to this work.
Conflict of interest
The authors declare no conflict of interest.
Figure 6.
(a) Normalized magnetic field distribution (H=H0). (b) Normalized MNP concentration profile after 48 h
(Cmnp=Cm,0). (c) MSC density after 24 h (Cc=Cc,0).
15
Biomedical Applications of Biomaterials Functionalized with Magnetic Nanoparticles
DOI: http://dx.doi.org/10.5772/intechopen.89199
Abbreviations
BMP-2 bone morphogenetic protein-2
DLS dynamic light scattering
ECM extracellular matrix
FIB fibrosarcoma
FEM finite element method
FF ferrofluid
GF growth factor
MagS magnetic scaffold
MDD magnetic drug delivery
MF magnetic field
MHA magnetic hydroxyapatite
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MNP magnetic nanoparticle
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RF radio frequency
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TEM transmission electron microscope
VEGF vascular endothelial growth factor
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